Contemporary Clinical Trials Communications (Sep 2018)

Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding

  • Jiacheng Yuan,
  • Daniel Radecki,
  • Denise Bugarin,
  • Till Geib,
  • Jihao Zhou,
  • Jeen Liu

Journal volume & issue
Vol. 11
pp. 83 – 88

Abstract

Read online

This paper considers combining a proof of concept (POC) study and a dose finding (DF) study where the POC and the DF share the same primary endpoint. An example based on real study conditions shows that compared to a conventional design the proposed adaptive design tests more active doses, with a smaller sample size and a shorter overall duration leading to a budget saving of 30% in study operations. Keywords: Adaptive design, Dose finding, Proof of concept, Seamless design, Budget saving